🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the effects of rosuvastatin compared...
Status
Completed
Location
Research site
Start Date
2002-11
Trial ID
NCT00800800
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
The purpose of this study is to investigate whether rosuvastatin decreases ...
Status
Withdrawn
Location
Akershus University Hospital
Start Date
2009-09
Trial ID
NCT00951132
Treatments Being Tested
To investigate the efficacy and safety after administration of HCP1105 in h...
Status
Unknown
Location
Euljii General Hospital
Start Date
2014-10
Trial ID
NCT02551172
Treatments Being Tested
Study of efficacy, safety, tolerability and quality of life of inclisiran (...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-04-08
Trial ID
NCT05192941
Treatments Being Tested
This is a study to evaluate the effect on LDL-C and the safety and tolerabi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-17
Trial ID
NCT07619131
This study will assess the safety, tolerability, pharmacokinetics (PK), and...
Status
Completed
Location
Research Site
Start Date
2022-05-18
Trial ID
NCT05384262
The objective of this study is * To evaluate the efficacy of PRC-4016 by a...
Status
Terminated
Location
Medical Affiliated Research Center, Inc.
Start Date
2013-11
Trial ID
NCT01972178
Study aims to evaluate clinical and radiographic effectiveness of 1.2% Rosu...
Status
Completed
Location
Sukhada Deo
Start Date
2016-01-28
Trial ID
NCT03677297
Treatments Being Tested
Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Status
Completed
Location
Investigational Site Number 840857
Start Date
2012-07
Trial ID
NCT01644175
Treatments Being Tested